High Uptake of FDG Along a Biliary Stent

被引：6

作者：

Nagasaki, Yasunari ^{[1
]}

Yamane, Hiromichi ^{[2
]}

Ochi, Nobuaki ^{[2
]}

Honda, Yoshihiro ^{[2
]}

Takigawa, Nagio ^{[2
]}

机构：

[1] Kawasaki Hosp, Kawasaki Med Sch, Clin Educ & Training Ctr, Okayama, Japan

[2] Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan

来源：

CLINICAL NUCLEAR MEDICINE | 2016年 / 41卷 / 11期

关键词：

biliary stent; chemotherapy; FDG-PET-CT; pancreatic cancer; PET/CT; GEMCITABINE;

D O I：

10.1097/RLU.0000000000001357

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 66-year-old woman presented with abdominal discomthrt. Contrast-enhanced CT revealed a mass in the pancreas and multiple liver metastases. Pathological examination confirmed the mass to be primary pancreatic cancer. Endoscopic insertion of a biliary stent was performed to prevent common bile duct obstruction. Subsequently, she received combination chemotherapy, which resulted in a complete response. FDG-PETCT after chemotherapy revealed a high uptake of FDG along the outline of the biliary stcnt, with complete disappearance of both the primary and metastatic tumors.

引用

页码：890 / +

页数：2

共 9 条

[1] The Value of F-18 FDG PET in Patients With Primary Sclerosing Cholangitis and Cholangiocarcinoma Using Visual and Semiquantitative Analysis [J].

Alkhawaldeh, Khaled ;

Faltten, Stephanie ;

Biersack, Hans-J. ;

Ezziddin, Samer .

CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) :879-883

[2] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].

Conroy, Thierry ;

Desseigne, Francoise ;

Ychou, Marc ;

Bouche, Olivier ;

Guimbaud, Rosine ;

Becouarn, Yves ;

Adenis, Antoine ;

Raoul, Jean-Luc ;

Gourgou-Bourgade, Sophie ;

de la Fouchardiere, Christelle ;

Bennouna, Jaafar ;

Bachet, Jean-Baptiste ;

Khemissa-Akouz, Faiza ;

Pere-Verge, Denis ;

Delbaldo, Catherine ;

Assenat, Eric ;

Chauffert, Bruno ;

Michel, Pierre ;

Montoto-Grillot, Christine ;

Ducreux, Michel .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825

[3] Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study [J].

Gruenberger, Birgit ;

Schueller, Johannes ;

Heubrandtner, Ute ;

Wrba, Fritz ;

Tamandl, Dietmar ;

Kaczirek, Klaus ;

Roka, Rudolf ;

Pircher, Sandra Freimann ;

Gruenberger, Thomas .

LANCET ONCOLOGY, 2010, 11 (12) :1142-1148

[4] Usefulness of Dual-Phase 18F-FDG PET/CT for Diagnosing Small Pancreatic Tumors [J].

Kawada, Natsuko ;

Uehara, Hiroyuki ;

Hosoki, Takuya ;

Takami, Motohisa ;

Shiroeda, Hisakazu ;

Arisawa, Tomiyasu ;

Tomita, Yasuhiko .

PANCREAS, 2015, 44 (04) :655-659

[5] Biliary tract FDG uptake secondary to stent placement [J].

Lin, EC ;

Studley, M .

CLINICAL NUCLEAR MEDICINE, 2003, 28 (04) :318-319

[6] Brush cytology for pancreatic carcinoma: An analysis of factors influencing results [J].

McGuire, DE ;

Venu, RP ;

Brown, RD ;

Etzkorn, KP ;

Glaws, WR ;

AbuHammour, A .

GASTROINTESTINAL ENDOSCOPY, 1996, 44 (03) :300-304

[7] FDG-PET/CT Manifestation of Tumor Seeding Along Percutaneous Biliary Drainage Catheter Tract [J].

Patel, Darshan ;

Lu, Yang .

CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) :830-831

[8] Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings [J].

Zhang, Jian ;

Shao, Chengwei ;

Wang, Jianhua ;

Cheng, Chao ;

Zuo, Changjing ;

Sun, Gaofeng ;

Cui, Bin ;

Dong, Aisheng ;

Liu, Qinghua ;

Kong, Lingshan .

ABDOMINAL IMAGING, 2013, 38 (03) :543-549

[9]

Zhao Z, 2016, CLIN EXP RHEUMATOL, V34, P119

← 1 →